| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 NFIA ZNF283 ZFP69B ZNF606 KDM6A FOXK1 ZFP62 HNF1A ZFP90 ZBTB2 TCF12 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 DMRT2 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A SMAD4 | 2.08e-12 | 1459 | 215 | 48 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 NFIA ZNF283 ZFP69B ZNF606 FOXK1 ZFP62 HNF1A ZFP90 ZBTB2 TCF12 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF17 ZNF20 ZNF100 DMRT2 ZBED6 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A SMAD4 | 2.47e-12 | 1412 | 215 | 47 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | KLF8 ZNF140 SALL3 ZNF157 ZNF460 ZNF268 ZNF549 ZNF571 ZNF302 ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 NFIA ZNF283 ZNF606 KDM6A FOXK1 ZFP62 HNF1A ZBTB2 TCF12 ZNF570 ZFP28 ZNF322 ZNF850 ZNF710 ZNF17 ZNF100 DMRT2 MTOR ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A SMAD4 | 2.12e-10 | 1271 | 215 | 41 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | KLF8 ZNF140 SALL3 ZNF157 ZNF460 ZNF268 ZNF549 ZNF571 ZNF302 ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 NFIA ZNF283 ZNF606 KDM6A FOXK1 ZFP62 HNF1A ZBTB2 TCF12 ZNF570 ZFP28 ZNF322 ZNF850 ZNF710 ZNF17 ZNF100 DMRT2 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A SMAD4 | 4.04e-10 | 1244 | 215 | 40 | GO:0000978 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 8.73e-05 | 9 | 216 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | non-motile cilium | 2.10e-04 | 196 | 216 | 9 | GO:0097730 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.64e-04 | 14 | 216 | 3 | GO:0072379 | |
| Domain | Znf_C2H2/integrase_DNA-bd | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 1.40e-20 | 694 | 216 | 44 | IPR013087 |
| Domain | zf-C2H2 | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 9.28e-20 | 693 | 216 | 43 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 HELZ2 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 1.53e-19 | 775 | 216 | 45 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 HELZ2 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 1.70e-19 | 777 | 216 | 45 | PS00028 |
| Domain | - | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF571 ZNF302 ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 2.97e-19 | 679 | 216 | 42 | 3.30.160.60 |
| Domain | Znf_C2H2-like | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 HELZ2 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 4.35e-19 | 796 | 216 | 45 | IPR015880 |
| Domain | ZnF_C2H2 | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 HELZ2 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 7.77e-19 | 808 | 216 | 45 | SM00355 |
| Domain | Znf_C2H2 | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZNF703 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 4.12e-18 | 805 | 216 | 44 | IPR007087 |
| Domain | zf-C2H2_6 | ZNF140 ZNF157 ZNF549 ZNF571 ZNF302 ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZFP62 ZFP90 ZNF570 ZFP28 ZNF850 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF84 ZNF333 ZNF682 ZNF286A | 4.55e-18 | 314 | 216 | 29 | PF13912 |
| Domain | KRAB | ZNF140 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF461 ZNF836 ZNF530 ZNF283 ZFP69B ZNF606 ZFP90 ZNF570 ZFP28 ZNF850 ZNF529 ZNF169 ZNF17 ZNF20 ZNF100 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 1.76e-17 | 358 | 216 | 30 | PS50805 |
| Domain | KRAB | ZNF140 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF461 ZNF836 ZNF530 ZNF283 ZFP69B ZNF606 ZFP90 ZNF570 ZFP28 ZNF850 ZNF529 ZNF169 ZNF17 ZNF20 ZNF100 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 1.76e-17 | 358 | 216 | 30 | PF01352 |
| Domain | KRAB | ZNF140 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF461 ZNF836 ZNF530 ZNF283 ZFP69B ZNF606 ZFP90 ZNF570 ZFP28 ZNF850 ZNF529 ZNF169 ZNF17 ZNF20 ZNF100 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 4.07e-17 | 369 | 216 | 30 | SM00349 |
| Domain | KRAB | ZNF140 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF461 ZNF836 ZNF530 ZNF283 ZFP69B ZNF606 ZFP90 ZNF570 ZFP28 ZNF850 ZNF529 ZNF169 ZNF17 ZNF20 ZNF100 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 4.39e-17 | 370 | 216 | 30 | IPR001909 |
| Domain | DUF2012 | 6.05e-06 | 4 | 216 | 3 | PF09430 | |
| Domain | DUF2012 | 6.05e-06 | 4 | 216 | 3 | IPR019008 | |
| Domain | Ig-like_fold | FSTL5 OBSCN CMYA5 AMIGO1 IGSF22 HMCN2 NOMO2 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLNA FLT4 ADAMTSL1 MILR1 NOMO1 CSF3R ATF7IP KIR3DL3 LRRN4 NOMO3 | 7.90e-06 | 706 | 216 | 23 | IPR013783 |
| Domain | ig | FSTL5 OBSCN AMIGO1 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLT4 KIR3DL3 | 1.37e-05 | 190 | 216 | 11 | PF00047 |
| Domain | Immunoglobulin | FSTL5 OBSCN AMIGO1 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLT4 KIR3DL3 | 1.37e-05 | 190 | 216 | 11 | IPR013151 |
| Domain | Carb-bd-like_fold | 8.18e-05 | 8 | 216 | 3 | IPR013784 | |
| Domain | - | FSTL5 OBSCN CMYA5 AMIGO1 IGSF22 NOMO2 NECTIN4 KIR2DL3 KIR2DS1 CDON HSPG2 FLNA FLT4 ADAMTSL1 MILR1 NOMO1 CSF3R ATF7IP LRRN4 NOMO3 | 9.19e-05 | 663 | 216 | 20 | 2.60.40.10 |
| Domain | IG | FSTL5 OBSCN AMIGO1 IGSF22 HMCN2 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLT4 ADAMTSL1 MILR1 KIR3DL3 | 1.21e-04 | 421 | 216 | 15 | SM00409 |
| Domain | Ig_sub | FSTL5 OBSCN AMIGO1 IGSF22 HMCN2 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLT4 ADAMTSL1 MILR1 KIR3DL3 | 1.21e-04 | 421 | 216 | 15 | IPR003599 |
| Domain | HEAT_REPEAT | 1.58e-04 | 70 | 216 | 6 | PS50077 | |
| Domain | Ig_I-set | 3.78e-04 | 190 | 216 | 9 | IPR013098 | |
| Domain | I-set | 3.78e-04 | 190 | 216 | 9 | PF07679 | |
| Domain | FerA | 3.96e-04 | 3 | 216 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 3.96e-04 | 3 | 216 | 2 | IPR012560 | |
| Domain | FerA | 3.96e-04 | 3 | 216 | 2 | PF08165 | |
| Domain | - | 3.96e-04 | 3 | 216 | 2 | 3.40.50.10130 | |
| Domain | DNA_repair_nuc_XPF/helicase | 3.96e-04 | 3 | 216 | 2 | IPR020819 | |
| Domain | CarboxyPept_regulatory_dom | 4.00e-04 | 13 | 216 | 3 | IPR014766 | |
| Domain | - | 4.00e-04 | 13 | 216 | 3 | 2.60.40.1120 | |
| Domain | EGF_CA | 5.47e-04 | 122 | 216 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.02e-04 | 124 | 216 | 7 | IPR001881 | |
| Domain | IG_LIKE | FSTL5 OBSCN AMIGO1 IGSF22 HMCN2 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLT4 ADAMTSL1 MILR1 KIR3DL3 | 6.18e-04 | 491 | 216 | 15 | PS50835 |
| Domain | Glyco_hydro_1_N_CS | 7.87e-04 | 4 | 216 | 2 | IPR033132 | |
| Domain | DysFC | 7.87e-04 | 4 | 216 | 2 | SM00694 | |
| Domain | DysFN | 7.87e-04 | 4 | 216 | 2 | SM00693 | |
| Domain | Glyco_hydro_1_AS | 7.87e-04 | 4 | 216 | 2 | IPR018120 | |
| Domain | Peroxin/Ferlin | 7.87e-04 | 4 | 216 | 2 | IPR006614 | |
| Domain | Ig-like_dom | FSTL5 OBSCN AMIGO1 IGSF22 HMCN2 NECTIN4 KIR2DL3 KIR2DS1 KIR2DS5 CDON HSPG2 FLT4 ADAMTSL1 MILR1 CSF3R | 7.91e-04 | 503 | 216 | 15 | IPR007110 |
| Domain | CarboxyPept-like_regulatory | 9.20e-04 | 17 | 216 | 3 | IPR008969 | |
| Domain | FerI | 1.30e-03 | 5 | 216 | 2 | SM01202 | |
| Domain | FerB | 1.30e-03 | 5 | 216 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.30e-03 | 5 | 216 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.30e-03 | 5 | 216 | 2 | PF16165 | |
| Domain | GLYCOSYL_HYDROL_F1_1 | 1.30e-03 | 5 | 216 | 2 | PS00572 | |
| Domain | Ferlin_C | 1.30e-03 | 5 | 216 | 2 | IPR032362 | |
| Domain | Glyco_hydro_1 | 1.30e-03 | 5 | 216 | 2 | PF00232 | |
| Domain | FerIin_dom | 1.30e-03 | 5 | 216 | 2 | IPR012968 | |
| Domain | FerI | 1.30e-03 | 5 | 216 | 2 | PF08151 | |
| Domain | FerB | 1.30e-03 | 5 | 216 | 2 | PF08150 | |
| Domain | GLYCOSYL_HYDROL_F1_2 | 1.30e-03 | 5 | 216 | 2 | PS00653 | |
| Domain | Restrct_endonuc-II-like | 1.30e-03 | 5 | 216 | 2 | IPR011335 | |
| Domain | ERCC4 | 1.30e-03 | 5 | 216 | 2 | SM00891 | |
| Domain | ERCC4_domain | 1.30e-03 | 5 | 216 | 2 | IPR006166 | |
| Domain | ERCC4 | 1.30e-03 | 5 | 216 | 2 | PF02732 | |
| Domain | Glyco_hydro_1 | 1.30e-03 | 5 | 216 | 2 | IPR001360 | |
| Domain | IGc2 | 1.70e-03 | 235 | 216 | 9 | SM00408 | |
| Domain | Ig_sub2 | 1.70e-03 | 235 | 216 | 9 | IPR003598 | |
| Domain | - | PIK3AP1 AGAP5 ANKS4B ANKRD53 ASB10 ANKFY1 ANKRD60 TP53BP2 PPP1R27 | 2.45e-03 | 248 | 216 | 9 | 1.25.40.20 |
| Domain | ANK | AGAP5 ANKS4B ANKRD53 ASB10 ANKFY1 RIPK4 ANKRD60 TP53BP2 PPP1R27 | 2.66e-03 | 251 | 216 | 9 | SM00248 |
| Domain | RNA_pol_II-bd | 2.69e-03 | 7 | 216 | 2 | IPR006903 | |
| Domain | CTD_bind | 2.69e-03 | 7 | 216 | 2 | PF04818 | |
| Domain | ZnF_UBR1 | 2.69e-03 | 7 | 216 | 2 | SM00396 | |
| Domain | ZF_UBR | 2.69e-03 | 7 | 216 | 2 | PS51157 | |
| Domain | zf-UBR | 2.69e-03 | 7 | 216 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.69e-03 | 7 | 216 | 2 | IPR003126 | |
| Domain | ANK_REPEAT | AGAP5 ANKS4B ANKRD53 ASB10 ANKFY1 RIPK4 ANKRD60 TP53BP2 PPP1R27 | 2.80e-03 | 253 | 216 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | PIK3AP1 AGAP5 ANKS4B ANKRD53 ASB10 ANKFY1 ANKRD60 TP53BP2 PPP1R27 | 2.88e-03 | 254 | 216 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | AGAP5 ANKS4B ANKRD53 ASB10 ANKFY1 RIPK4 ANKRD60 TP53BP2 PPP1R27 | 2.88e-03 | 254 | 216 | 9 | PS50297 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF140 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 PSMD2 ZNF571 ZNF302 ZNF461 ZNF71 ZNF530 RPRD2 ZFP69B ZNF606 CARM1 ZNF703 ZFP90 TCF12 RBBP8 ZNF570 KAT6A ZFP28 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 MTOR ZNF470 ZNF528 ZNF333 ZNF682 TP53BP2 ZNF286A HTT SMAD4 | 1.40e-07 | 1387 | 158 | 38 | M734 |
| Pubmed | ACACB RCC1 SALL2 ALMS1 GCN1 ARHGAP21 FLNA ANKFY1 RBBP8 UBR4 WDR6 ATF7IP ZNF516 DOCK7 TMF1 TP53BP2 | 1.18e-08 | 418 | 219 | 16 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | REPS1 OBSCN WASHC2A PLEKHG1 ULK4 HERC1 GCN1 ARHGAP21 FOXK1 HSPG2 FLNA CTC1 ESYT1 UBR4 KAT6A HECTD4 AKNA MUS81 CTDNEP1 MYOF MTOR NISCH ZNF516 HELZ2 HTT | 3.88e-08 | 1105 | 219 | 25 | 35748872 |
| Pubmed | EPC2 KLF8 ACACB BMS1 PSMD2 FLG2 WASHC2A SALL2 GANAB ALMS1 NFIA RPRD2 HERC1 KDM6A FOXK1 ZNF703 HSPG2 HNF1A TCF12 SCAF8 UBR4 MRPS18C ZNF850 TAB3 ATF7IP ZNF516 MARF1 OTUD4 | 1.13e-07 | 1429 | 219 | 28 | 35140242 | |
| Pubmed | 1.77e-07 | 21 | 219 | 5 | 7865130 | ||
| Pubmed | KLF8 PSMD2 ZNF571 CMYA5 NCAPG2 ZNF836 GANAB ZNF606 FOXK1 ZFP62 NOL9 NARS2 GFM2 ZNF100 ZNF682 | 2.11e-07 | 451 | 219 | 15 | 36168627 | |
| Pubmed | RCC1 MTCL1 ITPRIPL1 FOXK1 KLHL6 FLNA KAT6A MYOF EYS WDR6 ZBED6 HELZ2 TP53BP2 | 2.21e-07 | 332 | 219 | 13 | 37433992 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.46e-07 | 3 | 219 | 3 | 25576386 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PSMD2 HMGCS1 GANAB NOMO2 GCN1 FLNA ESYT1 UBR4 NOMO1 MYOF HELZ2 NOMO3 HTT | 3.32e-07 | 344 | 219 | 13 | 30333137 |
| Pubmed | FSTL5 CSMD3 WASHC2A ADCY2 PLEKHG1 GANAB NAV3 MTCL1 ARHGAP21 ANKFY1 SCAF8 NISCH DOCK7 OTUD4 | 3.62e-07 | 407 | 219 | 14 | 12693553 | |
| Pubmed | SYTL2 AMIGO1 ZNF836 ALMS1 NFIA ADAMTS9 TMEM41B ZNF606 ZBTB2 ZFP28 FANCM MYOF VPS13D HELZ2 ZNF286A | 6.49e-07 | 493 | 219 | 15 | 15368895 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 9.81e-07 | 4 | 219 | 3 | 31833031 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 9267806 | ||
| Pubmed | 1.46e-06 | 14 | 219 | 4 | 19875891 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.46e-06 | 14 | 219 | 4 | 15896204 | |
| Pubmed | ADGRV1 ZNF518A SALL2 ALMS1 RPRD2 GCN1 ANKFY1 MYOF HELZ2 ZNF286A | 1.84e-06 | 225 | 219 | 10 | 12168954 | |
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 20082646 | ||
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 20356536 | ||
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 19926642 | ||
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 20643584 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 1.98e-06 | 15 | 219 | 4 | 17498266 | |
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 19326408 | ||
| Pubmed | PSAP REPS1 PSMD2 ZNF302 GNPTG CMYA5 LRP1B ZNF836 ADAMTS9 NOMO2 TRIM8 NAV3 ZNF606 WDR17 KDM6A ARHGAP21 UBR4 HECTD4 WHAMM RIPK4 MICAL2 NISCH ZNF528 ZNF84 | 2.25e-06 | 1285 | 219 | 24 | 35914814 | |
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 19897003 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 19000141 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 20670355 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 18668235 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 19309280 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 2.62e-06 | 16 | 219 | 4 | 16403292 | |
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 2.62e-06 | 16 | 219 | 4 | 19527230 | |
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 20652381 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 19279038 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 17868255 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 18643961 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 20331834 | ||
| Pubmed | 2.62e-06 | 16 | 219 | 4 | 20210919 | ||
| Pubmed | ACACB ADCY2 DSN1 NFIA TRIM8 MTCL1 FER1L5 WDR17 KDM6A ANKFY1 UBR4 NARS2 RAD51AP2 ZNF516 OTUD4 NOMO3 | 3.36e-06 | 638 | 219 | 16 | 31182584 | |
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 19968064 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 3.41e-06 | 17 | 219 | 4 | 20878400 | |
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 20650299 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 19032228 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 20173784 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 20173792 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 20483367 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 3.41e-06 | 17 | 219 | 4 | 19218127 | |
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 19169284 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 19450876 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 4.37e-06 | 18 | 219 | 4 | 19630074 | |
| Pubmed | 4.37e-06 | 18 | 219 | 4 | 20200544 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 4.37e-06 | 18 | 219 | 4 | 19046302 | |
| Pubmed | 4.37e-06 | 18 | 219 | 4 | 20580654 | ||
| Pubmed | 4.37e-06 | 18 | 219 | 4 | 20519398 | ||
| Pubmed | 4.37e-06 | 18 | 219 | 4 | 19846535 | ||
| Pubmed | 5.31e-06 | 150 | 219 | 8 | 32423001 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 5.50e-06 | 19 | 219 | 4 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 5.50e-06 | 19 | 219 | 4 | 18778326 | |
| Pubmed | 5.50e-06 | 19 | 219 | 4 | 20600442 | ||
| Pubmed | 5.50e-06 | 19 | 219 | 4 | 18848853 | ||
| Pubmed | PSAP SYTL2 ZNF518A HERC1 KDM6A HSPG2 FLNA FLT4 UBR4 NOMO1 ATF7IP TOPORS NOMO3 TP53BP2 SMAD4 | 5.94e-06 | 591 | 219 | 15 | 15231748 | |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 6.85e-06 | 20 | 219 | 4 | 20193031 | |
| Pubmed | PSMD2 NCAPG2 DSN1 RPRD2 CARM1 ZBTB2 TCF12 CTC1 RBBP8 MUS81 FANCM CENPI TOPORS | 6.89e-06 | 453 | 219 | 13 | 29656893 | |
| Pubmed | 8.42e-06 | 21 | 219 | 4 | 19861144 | ||
| Pubmed | SALL3 ACACB ZNF157 PSMD2 SALL2 GANAB PCDH15 GCN1 ZBTB2 UBR4 SMAD4 TRMT61A | 9.09e-06 | 396 | 219 | 12 | 26687479 | |
| Pubmed | 1.02e-05 | 22 | 219 | 4 | 20492596 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.35e-05 | 8 | 219 | 3 | 15257293 | |
| Pubmed | 1.35e-05 | 8 | 219 | 3 | 18681957 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | EPC2 PSAP ACACB FLG2 ALMS1 NFIA KDM6A FOXK1 ZNF703 WDR6 ZNF516 | 1.58e-05 | 351 | 219 | 11 | 38297188 |
| Pubmed | KLF8 SALL3 RBM26 ZNF836 KDM6A ZNF653 FOXK1 HNF1A ANKFY1 TCF12 ZFP28 ZNF322 ZNF710 ZFP64 ZNF516 ZNF286A SMAD4 | 1.64e-05 | 808 | 219 | 17 | 20412781 | |
| Pubmed | 1.75e-05 | 51 | 219 | 5 | 11853319 | ||
| Pubmed | PSAP REPS1 OBSCN ZNF302 CMYA5 STRADB ALMS1 ADAMTS9 ARHGAP21 HSPG2 ANKFY1 TCF12 SMAD4 | 1.83e-05 | 497 | 219 | 13 | 23414517 | |
| Pubmed | PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. | 1.96e-05 | 130 | 219 | 7 | 26598620 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.01e-05 | 9 | 219 | 3 | 36261522 | |
| Pubmed | 2.09e-05 | 181 | 219 | 8 | 37372979 | ||
| Pubmed | 2.56e-05 | 304 | 219 | 10 | 32235678 | ||
| Pubmed | 2.86e-05 | 10 | 219 | 3 | 12559621 | ||
| Pubmed | 2.86e-05 | 10 | 219 | 3 | 21206914 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 3.21e-05 | 29 | 219 | 4 | 20082482 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PIK3AP1 DLG5 ACACB PKD1L1 WASHC2A LRP1B PLEKHG1 GANAB ALMS1 NOMO2 TMEM41B ARHGAP21 ESYT1 FPGS CEP164 TAB3 TP53BP2 | 3.25e-05 | 853 | 219 | 17 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EPC2 ZNF268 RBM26 BMS1 RCC1 SALL2 NFIA FOXK1 ZBTB2 TCF12 ESYT1 UBR4 NOL9 NISCH TMF1 RITA1 SMAD4 | 3.44e-05 | 857 | 219 | 17 | 25609649 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | BMS1 OBSCN PSMD2 HEATR5B FLNA ANKFY1 TAB3 IGHMBP2 OTUD4 TRMT61A | 3.55e-05 | 316 | 219 | 10 | 31665637 |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 3.91e-05 | 11 | 219 | 3 | 32820719 | |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 3.91e-05 | 11 | 219 | 3 | 19664392 | |
| Pubmed | The mucolipidosis IV Ca2+ channel TRPML1 (MCOLN1) is regulated by the TOR kinase. | 3.95e-05 | 2 | 219 | 2 | 26195823 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 18682925 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 38879600 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 19036965 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 26255774 | ||
| Pubmed | BCAP links IL-1R to the PI3K-mTOR pathway and regulates pathogenic Th17 cell differentiation. | 3.95e-05 | 2 | 219 | 2 | 30093533 | |
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 31002357 | ||
| Pubmed | 3.95e-05 | 2 | 219 | 2 | 15004467 | ||
| Pubmed | Cep164, a novel centriole appendage protein required for primary cilium formation. | 3.95e-05 | 2 | 219 | 2 | 17954613 | |
| Pubmed | Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. | 3.95e-05 | 2 | 219 | 2 | 21531719 | |
| Pubmed | Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling. | 3.95e-05 | 2 | 219 | 2 | 28192161 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 4.21e-05 | 31 | 219 | 4 | 19136429 | |
| Pubmed | 4.48e-05 | 101 | 219 | 6 | 10997877 | ||
| Pubmed | REPS1 RBM26 RCC1 ALMS1 RPRD2 GCN1 KDM6A FLNA TAB3 WDR6 DOCK7 TP53BP2 HTT | 5.10e-05 | 549 | 219 | 13 | 38280479 | |
| Pubmed | 5.20e-05 | 12 | 219 | 3 | 20371502 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 5.20e-05 | 12 | 219 | 3 | 17490516 | |
| Pubmed | 5.20e-05 | 12 | 219 | 3 | 19936734 | ||
| Cytoband | 19q13.4 | 1.11e-07 | 79 | 219 | 7 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF460 ZNF549 ZNF571 ZNF302 ZNF461 ZNF71 ZNF836 ZNF530 ZNF283 KIR2DL3 ZNF606 ZNF570 ZFP28 ZNF850 ZNF529 ZNF17 KIR3DL3 ZNF470 ZNF528 | 5.28e-06 | 1192 | 219 | 19 | chr19q13 |
| Cytoband | 19q13.12 | 4.02e-04 | 72 | 219 | 4 | 19q13.12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | KLF8 ZNF140 SALL3 ZNF157 ZNF337 ZNF460 ZNF268 ZNF549 ZNF177 ZNF571 ZNF302 ZNF518A ZNF461 ZNF71 ZNF836 ZNF117 SALL2 ZNF530 ZNF283 ZFP69B ZNF606 ZNF653 ZFP62 ZFP90 ZBTB2 ZNF570 ZFP28 ZNF322 ZNF850 ZNF529 ZNF169 ZNF710 ZNF17 ZNF20 ZNF100 ZFP64 ZNF516 ZNF470 ZNF528 ZNF84 ZNF333 ZNF682 ZNF286A | 1.01e-24 | 718 | 155 | 43 | 28 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.45e-05 | 18 | 155 | 4 | 620 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.55e-05 | 161 | 155 | 8 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | AGAP5 ANKS4B ANKRD53 ASB10 ANKFY1 RIPK4 ANKRD60 TP53BP2 PPP1R27 | 2.45e-04 | 242 | 155 | 9 | 403 |
| GeneFamily | Fibronectin type III domain containing | 4.64e-04 | 160 | 155 | 7 | 555 | |
| GeneFamily | Ferlin family | 1.07e-03 | 6 | 155 | 2 | 828 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.49e-03 | 7 | 155 | 2 | 785 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DSN1 AMIGO1 SALL2 NAV3 OSBPL10 CARM1 MAP2K4 FLT4 CTC1 NARS2 KCTD3 | 6.65e-10 | 167 | 217 | 11 | 961e722442d786ab15d1e490941d2be265a9057a |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DSN1 AMIGO1 SALL2 NAV3 OSBPL10 CARM1 MAP2K4 FLT4 CTC1 NARS2 KCTD3 | 6.65e-10 | 167 | 217 | 11 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.17e-06 | 159 | 217 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 174 | 217 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.24e-06 | 189 | 217 | 8 | a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.24e-06 | 189 | 217 | 8 | 54a45b0cb7dea01caf1cf0a2664c40e5779a0b61 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.52e-06 | 135 | 217 | 7 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.58e-06 | 191 | 217 | 8 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.28e-06 | 148 | 217 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-05 | 171 | 217 | 7 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 3.62e-05 | 186 | 217 | 7 | d7da5edb2ee36f96cdd7e27eb9afcc1cbfd52bb6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 186 | 217 | 7 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-05 | 188 | 217 | 7 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.90e-05 | 128 | 217 | 6 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.01e-05 | 189 | 217 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-05 | 130 | 217 | 6 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 192 | 217 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.43e-05 | 192 | 217 | 7 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 192 | 217 | 7 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 194 | 217 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.73e-05 | 194 | 217 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.73e-05 | 194 | 217 | 7 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.73e-05 | 194 | 217 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 194 | 217 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | PBMC-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 4.74e-05 | 81 | 217 | 5 | 6d1e524f000b71c935359afc801a1d31f218fec8 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.84e-05 | 133 | 217 | 6 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.89e-05 | 195 | 217 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.89e-05 | 195 | 217 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue | 5.26e-05 | 135 | 217 | 6 | 11a672ab6cba7026b8d81d8b216443cb88c0d47a | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.38e-05 | 198 | 217 | 7 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.55e-05 | 199 | 217 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 5.55e-05 | 199 | 217 | 7 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Sigmoid-T_cell-Tfh|T_cell / Region, Cell class and subclass | 5.73e-05 | 200 | 217 | 7 | dd7dcf25520f065bf0d33d589f3c176f63875dc9 | |
| ToppCell | severe-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.73e-05 | 200 | 217 | 7 | 804c6e998fb7a29ca1b98f53d5dbcb7ae5a47e7a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.19e-05 | 139 | 217 | 6 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.19e-05 | 139 | 217 | 6 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.82e-05 | 145 | 217 | 6 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 8.76e-05 | 148 | 217 | 6 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.76e-05 | 148 | 217 | 6 | 065177aaa63c0441d312260b43ecdac78c84ad03 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-05 | 149 | 217 | 6 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-05 | 149 | 217 | 6 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.09e-05 | 149 | 217 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 3.13e-06 | 5 | 202 | 3 | EFO_0004869, EFO_0006794 | |
| Disease | Metastatic melanoma | 3.45e-05 | 54 | 202 | 5 | C0278883 | |
| Disease | glycoproteinosis (is_implicated_in) | 4.66e-05 | 2 | 202 | 2 | DOID:3343 (is_implicated_in) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.52e-05 | 148 | 202 | 7 | C0279702 | |
| Disease | Benign tumor of pancreas | 8.59e-05 | 13 | 202 | 3 | C0347284 | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 1.39e-04 | 3 | 202 | 2 | OBA_2042107 | |
| Disease | Pancreatic carcinoma | 2.82e-04 | 19 | 202 | 3 | C0235974 | |
| Disease | skin hydration measurement | 3.84e-04 | 21 | 202 | 3 | EFO_0009586 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 9.13e-04 | 28 | 202 | 3 | DOID:8634 (is_marker_for) | |
| Disease | Glycosuria | 9.57e-04 | 7 | 202 | 2 | HP_0003076 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 9.57e-04 | 7 | 202 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, unipolar depression | 1.12e-03 | 30 | 202 | 3 | EFO_0003761, EFO_0006336 | |
| Disease | Epileptic encephalopathy | 1.12e-03 | 30 | 202 | 3 | C0543888 | |
| Disease | forced expiratory volume | CERKL ZNF337 PCDH15 RPRD2 MTCL1 CDON ADAMTSL1 RBBP8 WHAMM TSEN54 EYS DMRT2 IGHMBP2 OTUD4 | 1.14e-03 | 789 | 202 | 14 | EFO_0004314 |
| Disease | alcohol dependence, risky sexual behaviour measurement | 1.27e-03 | 8 | 202 | 2 | EFO_0007877, MONDO_0007079 | |
| Disease | colorectal cancer (is_implicated_in) | 1.50e-03 | 121 | 202 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 1.76e-03 | 35 | 202 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.92e-03 | 128 | 202 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.92e-03 | 128 | 202 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.92e-03 | 128 | 202 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.92e-03 | 128 | 202 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.92e-03 | 128 | 202 | 5 | C0007134 | |
| Disease | alcoholic liver disease | 2.46e-03 | 82 | 202 | 4 | EFO_0008573 | |
| Disease | coagulation factor XA measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0020266 | |
| Disease | craniosynostosis (is_implicated_in) | 2.94e-03 | 12 | 202 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | coagulation factor X measurement | 3.46e-03 | 13 | 202 | 2 | EFO_0020265 | |
| Disease | hyperglycemia (is_marker_for) | 3.46e-03 | 13 | 202 | 2 | DOID:4195 (is_marker_for) | |
| Disease | Disorder of eye | 3.50e-03 | 212 | 202 | 6 | C0015397 | |
| Disease | carotid artery intima media thickness | 4.02e-03 | 450 | 202 | 9 | EFO_0007117 | |
| Disease | revision of total hip arthroplasty | 4.02e-03 | 14 | 202 | 2 | EFO_0020973 | |
| Disease | sulfate measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0007864 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.05e-03 | 291 | 202 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Leigh Disease | 4.11e-03 | 47 | 202 | 3 | C0023264 | |
| Disease | alkaline phosphatase measurement | CDO1 DLG5 ACACB ZNF337 TRIM8 ARHGAP21 HSPG2 HNF1A MAP2K4 ADAMTSL1 ZFP28 SLC39A4 KIAA1614 ATF7IP LTBP2 | 4.43e-03 | 1015 | 202 | 15 | EFO_0004533 |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.62e-03 | 15 | 202 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 4.62e-03 | 15 | 202 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.62e-03 | 15 | 202 | 2 | C0154091 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 4.62e-03 | 15 | 202 | 2 | EFO_0801746 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 4.62e-03 | 15 | 202 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | N-acetylmethionine measurement | 4.62e-03 | 15 | 202 | 2 | EFO_0021427 | |
| Disease | Spondyloepiphyseal Dysplasia | 5.25e-03 | 16 | 202 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 5.25e-03 | 16 | 202 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 5.25e-03 | 16 | 202 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 5.25e-03 | 16 | 202 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 5.25e-03 | 16 | 202 | 2 | C0025237 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 5.25e-03 | 16 | 202 | 2 | C0393706 | |
| Disease | Uveal Melanoma | 5.76e-03 | 53 | 202 | 3 | EFO_1000616 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.76e-03 | 53 | 202 | 3 | C1961099 | |
| Disease | Van Buchem disease | 5.93e-03 | 17 | 202 | 2 | C0432272 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 5.95e-03 | 105 | 202 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 6.07e-03 | 54 | 202 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | apolipoprotein B measurement | ACACB NAGS AMIGO1 CARM1 HNF1A TCF12 ZFP28 MYOF NISCH DOCK7 HTT | 6.24e-03 | 663 | 202 | 11 | EFO_0004615 |
| Disease | factor VII measurement | 6.38e-03 | 55 | 202 | 3 | EFO_0004619 | |
| Disease | COVID-19, mortality | 6.42e-03 | 170 | 202 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | Carcinoma of bladder | 6.64e-03 | 18 | 202 | 2 | C0699885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSLATHQRIHVGERP | 311 | Q9HBT8 | |
| HTTPDSQFGTEHVLR | 636 | Q9BSJ8 | |
| HITSSAPELRQRLTH | 946 | Q9BSJ8 | |
| LVRTVGHTTTNHLIP | 696 | Q52LR7 | |
| TPTRLTQLHSLLLSH | 81 | Q86WK6 | |
| VPSHLTSNSHILRLE | 796 | Q7Z407 | |
| ILSLGRSHPAVTHVS | 246 | Q2NKJ3 | |
| AGSHEPIKIQTRSDH | 606 | Q99708 | |
| RLPSNHFLTIGSIHQ | 316 | O60477 | |
| LTTPLHVAASRGHTE | 116 | Q8WXI3 | |
| TLNVIRHHGTLSPVT | 1886 | Q8WXG9 | |
| LNTGHPLVTSEHTRR | 3831 | Q8TCU4 | |
| GETPISIAHRLNHTL | 286 | Q9BZ19 | |
| RPNETTIHTAGHSLA | 166 | Q9H2A7 | |
| TGGVITNIHLHSSPV | 196 | Q6MZZ7 | |
| LNDTLLHRVVPHGQS | 126 | P07384 | |
| QHPLLTTARGLVHDS | 91 | Q86YH6 | |
| TDLEITVPIRHSQHL | 671 | Q6ZUJ8 | |
| PAGKHIITTTRSHSN | 186 | O95861 | |
| VGPTHELVQSLISTH | 366 | Q14692 | |
| LLLTTSHHNALRTPD | 651 | Q9Y485 | |
| AVQSALTKTHTRGPH | 626 | Q13625 | |
| VGLVHSNIATEHIPS | 481 | Q01581 | |
| PHIERLRTHSIESSG | 71 | P45985 | |
| SLGTAFTQHHRPVIT | 341 | Q12857 | |
| SQLLPSTSIHDIHGI | 156 | Q09MP3 | |
| SHRSHSTEPGLVLTL | 26 | P18754 | |
| LSSTITVIAPTHHGN | 251 | Q5T8P6 | |
| PSILTLTAIRHHVLG | 656 | P69849 | |
| RGEHVHSLPEASVSS | 916 | Q01804 | |
| THGSQLRLHLVSPAD | 2971 | P98160 | |
| TSPAGHAEATIILHV | 3281 | P98160 | |
| SPHSRVQIGDHSLRL | 1106 | Q9Y4B5 | |
| HVLTEQSGLRVLHSP | 1501 | Q9Y4B5 | |
| AHSGRIPISLETQAH | 266 | Q9GZU1 | |
| HISPAERAQVVHLLS | 2436 | O00763 | |
| TPLHLVIHRDNTTVA | 176 | Q8N9V6 | |
| AEGRTPIHVAISSQH | 801 | Q9P2R3 | |
| ALRITHSDVAPTHIL | 556 | Q5SY16 | |
| HGQSESIVPERHGTT | 1681 | Q5D862 | |
| PSILTLTAIRHHVLG | 656 | Q5JPE7 | |
| STVTLPQLLAHLVSH | 76 | Q8NGR6 | |
| PQSIHQRGVLTVDHL | 456 | Q14667 | |
| VLPRGVSHHGSVTIR | 591 | Q8WZ60 | |
| VVSVSSKQGLLHPHR | 4106 | Q9NZR2 | |
| PFSVIGNTISHITHQ | 226 | Q6UB28 | |
| RSEPLNLSLGVHTVH | 2501 | Q5T1H1 | |
| SETGNPRHLHVLIGT | 236 | P43628 | |
| RADHSQTQGTLHLPT | 476 | Q9Y216 | |
| ESHTLTVREGHPTRL | 2176 | Q8NDA2 | |
| HLAGTHTSLRLPQEG | 1801 | Q8IYD8 | |
| GHTNHVREPTLVTGL | 4326 | Q15751 | |
| VTSLNSPHSGLHTIN | 841 | O15550 | |
| HDIVPTITQGSRDGH | 391 | Q5VZ46 | |
| IPLANTGIVNHTHSR | 536 | Q86X55 | |
| PIVTATGLTHHILAA | 1436 | Q8N6G6 | |
| ALLSSNITPIVTLHH | 141 | Q6UWM7 | |
| LSVVHRLGGPTSLLH | 271 | Q8NGF3 | |
| IDLPLSHHGSLSGLT | 1376 | Q8IVL0 | |
| LPVSVTGNSRHLHVL | 311 | Q8N743 | |
| IHVLRNHAVGPSTSL | 411 | Q99081 | |
| LGGIQRTHHDLTTPA | 521 | Q8TC05 | |
| PSILTLTAIRHHVLG | 656 | Q15155 | |
| LHPSVQHQGRLSLDL | 1221 | Q8TDM6 | |
| HLATPLDQSVSSHLG | 126 | Q96LU7 | |
| TGSQQILHVIHTIPS | 151 | O95600 | |
| LHHQTLPASTLRRTE | 131 | P09848 | |
| GQSHLLPSNHSVIET | 606 | P20823 | |
| LIISHHPSLVAVQSG | 671 | Q92616 | |
| IVDVLSRLPHHSSAV | 336 | Q8N159 | |
| TTHQVLHLVHTSGLP | 611 | Q96KJ4 | |
| HHESILNRPGLGSIV | 261 | Q8N8V4 | |
| TAHSRLLVISGIPTH | 2971 | Q9Y4D8 | |
| HTRTLSTHSVPNISG | 861 | P28290 | |
| IEGVRTHLLRHSEPS | 491 | Q9UKM7 | |
| RHITLHCLSVNGSLP | 141 | Q7Z6M3 | |
| LQVITLASGNVPHHT | 571 | Q8N475 | |
| SETGNPRHLHVLIGT | 236 | Q14953 | |
| HTLTIREVPASLHGA | 666 | Q5VST9 | |
| LLLRSAQPHHAGEVT | 4491 | Q5VST9 | |
| ILSLRQHQSLPHGAS | 426 | Q6GPH6 | |
| GICPQDITSTLHHLR | 721 | Q92794 | |
| ATDGAVHPRHSTLTL | 791 | Q96QU1 | |
| DITLSGHPRLSTQHV | 121 | Q9UFP1 | |
| TRPTETSNLEHLGHE | 271 | Q9UJJ9 | |
| TSNLEHLGHETPRAK | 276 | Q9UJJ9 | |
| VPGRVHISSVTLEHL | 421 | Q08462 | |
| SPGGIHHDTAVLLTR | 376 | Q9P2N4 | |
| GHDIITEQPRSQHTL | 491 | P42858 | |
| HGSATATLHLSVLEP | 686 | Q8N9C0 | |
| LSHVLDLVSHPRATQ | 331 | Q9P2D3 | |
| GNISHHTTVPLTEAV | 41 | Q96N67 | |
| HTPEIQTTRSDLQGH | 406 | Q9Y5R5 | |
| VTGPRLVSNHSLHET | 2516 | P21333 | |
| SIGLHRVENISHTEP | 136 | Q16878 | |
| ATTLLVGPRHGISHV | 411 | Q5JV73 | |
| TAHPALHISSSGTVI | 3906 | Q8N3K9 | |
| SHGLITSHPSQVLRS | 441 | Q4KMG0 | |
| HPIHQGITELSRSIS | 111 | Q9H410 | |
| SIVTSQQPAGHAIHV | 501 | P85037 | |
| SVILRSVHSAVNHTP | 166 | Q6IS24 | |
| PEHRLSHISTAGTLA | 941 | Q7Z591 | |
| LIPAGSTNVLAHSLH | 296 | Q49MI3 | |
| GTQESIITLPHLNHT | 81 | Q99062 | |
| LTLGSTGPQLTVHHR | 1111 | Q6VMQ6 | |
| HVGLSRTVRLHPTAT | 291 | Q14767 | |
| HLRLVVPTHGNSSAA | 671 | Q9Y4F3 | |
| VHSLLQTHEGTVPLL | 1011 | Q9Y4F3 | |
| THPVAHSGASILREA | 546 | Q05932 | |
| RSSVHHSSIPRAEGI | 736 | Q92674 | |
| ASRTPAVHRHVLSVL | 156 | P48637 | |
| EGRPNQSLRSITLHH | 2271 | Q9BYK8 | |
| RESLTLPSHSLEHLG | 1366 | Q5VT52 | |
| PHLIDHQISSGENTR | 771 | Q9UPN6 | |
| SALQIHLRSHTGERP | 386 | Q9Y467 | |
| SALQIHERTHTGEKP | 1126 | Q9BXA9 | |
| ISPATSVVQHSHLRE | 611 | Q9Y597 | |
| SLEHITHSLLGRPLS | 566 | O43933 | |
| PKLQVHGADHSRTSL | 2086 | Q8TDX9 | |
| RGDAQPHSHLVLTTR | 531 | P59044 | |
| RHATVAPVTVHGTLT | 1181 | Q8WYK1 | |
| STTRTQHRGEHAPEL | 451 | Q8WUT4 | |
| HLPHTSLGEALSRAV | 1201 | O94851 | |
| PIQSIGSSLHVLFHS | 206 | Q6UXH9 | |
| SETGNPRHLHVLIGT | 236 | Q14954 | |
| CSRLLTPSIHLISGH | 626 | P42345 | |
| ILHSHVQLPIVSTSA | 41 | Q8NET4 | |
| PINGLHSHSEVLTAR | 416 | Q9HCH5 | |
| TPNGHTTQTSLHRLV | 286 | Q8IW52 | |
| HPGTVQSELVRHSSF | 231 | Q8TC12 | |
| QDVAITLHSLTIHPG | 646 | Q969S9 | |
| VHRPVDADGLITHTS | 601 | Q96D71 | |
| LQHISVLQTTHLPDG | 421 | Q7Z6J9 | |
| RTLVHSSSDGHIDPQ | 96 | Q8N5C8 | |
| SASVHHNELVPTILR | 451 | Q8N4F4 | |
| HTQGLVPEHVETRTL | 1666 | A0AVI2 | |
| QTHTTPVLLAHGERA | 866 | Q13200 | |
| VHIHTPIITSNDSEG | 176 | Q96I59 | |
| PGTTNHDIALLRLHQ | 296 | P08709 | |
| GRHSHDEISILSPLS | 436 | Q96MK3 | |
| SLQLGPDSLTVHLIH | 66 | Q14697 | |
| SLSTEGHSIQTIQHP | 171 | Q13485 | |
| VELTHLGSPSAQREH | 111 | Q8NDX1 | |
| HSHGVSLQLAPSELR | 446 | Q6P5W5 | |
| QLLDTHLHIGTGPTA | 726 | A0A0B4J2F2 | |
| QLLDTHLHIGTGPTA | 726 | P57059 | |
| HAVSVIHPSSRKTRG | 581 | Q8TF30 | |
| VTGSNLPSHSDIHIS | 1261 | Q8IZU2 | |
| QTPLHVAAETGHTST | 686 | P57078 | |
| RHLSVGAPGVVTITH | 206 | Q9BXB5 | |
| LTHLVTAAVSLTHPG | 16 | Q9Y3D5 | |
| TAAVSLTHPGTHTVL | 21 | Q9Y3D5 | |
| RGLSHSLTHLNVPST | 196 | Q96K30 | |
| SVTLEIPHHITQRDA | 166 | A6NIR3 | |
| LRLLQHSHSQVPEAG | 1391 | Q9UPV0 | |
| SRHTDTPVHRGVLST | 996 | Q86XI2 | |
| TLIHSHHDGVLRPTV | 71 | O95476 | |
| ITPGTLRQLAITHHV | 151 | Q9H3H3 | |
| VHHIRESIPGVSLSS | 426 | Q96SZ6 | |
| SLATIHPSGLAALHE | 56 | Q86WC6 | |
| ILHLESPESGNHSTS | 366 | Q96JI7 | |
| GSDLALLQLAHPTTH | 126 | Q2L4Q9 | |
| TLLLSHNRISHLPSG | 716 | Q9NR97 | |
| IRSHRTGTLIQGHEP | 81 | Q92618 | |
| STLTTHRRIHTGEKP | 246 | Q8IYN0 | |
| SSLTVHQRIHTGEKP | 546 | Q8NHY6 | |
| SSLHESLHIGQSRTP | 131 | P82094 | |
| HRRTHTGETPLQCEI | 546 | Q96CK0 | |
| ELLSHLRTHTALPGA | 476 | Q9H7S9 | |
| RIHTAEKSHEPIQSG | 496 | Q14592 | |
| TLPVHERTHTGVNAD | 241 | P17024 | |
| SQLILHTRTHTGERP | 231 | P51786 | |
| FPTILGLLQHQTTHS | 191 | Q6P9A3 | |
| SLLIVHERTHAGVNP | 821 | Q14587 | |
| VPSSLQKHVRTHTGE | 351 | Q13360 | |
| GHPARLLESIQQHSL | 266 | P38935 | |
| HSESLHPTVLVQRGH | 511 | Q6ZQQ2 | |
| SVSHAIIRTIAPTGH | 116 | Q96FX7 | |
| IIRTIAPTGHLHTVE | 121 | Q96FX7 | |
| SGRHSPHALVLKEVT | 376 | P35916 | |
| IPHQESRGSSQHILS | 741 | Q9Y2I1 | |
| SDLISHQRTHTGERP | 196 | Q6U7Q0 | |
| SLLTIHERTHTGEKP | 326 | O95780 | |
| SHLQTHLLTHQGTRP | 336 | Q8N1W2 | |
| SIHLPLSRTLAGLHV | 606 | Q8IWV7 | |
| STLTLHQRIHTGEKP | 241 | Q6ECI4 | |
| SPTHLIKTRGQHVTL | 26 | A0A0A0MS05 | |
| NHLTQSHPEVLGTTI | 581 | Q6AHZ1 | |
| HLCSGTRLPALTVHV | 386 | P07602 | |
| LHTLPTREGHHLVAS | 986 | Q9NNW5 | |
| TVHTQLLGSDHPSEV | 321 | Q9HBF4 | |
| SSLATHQRTHTGEKP | 556 | P51523 | |
| QPSSLRSHVRTHTGE | 461 | Q96JL9 | |
| SEHRRSHGLESVPVL | 991 | Q641Q2 | |
| LGTSTLQRHLQATHP | 301 | P86452 | |
| HPSSLTQHVRIHTGE | 346 | Q9UJL9 | |
| HHGDNASRSPVVITI | 896 | Q9NS56 | |
| SSLTLHQRIHTGEKP | 231 | Q96NI8 | |
| SELIRHQITHTGEKP | 286 | P52738 | |
| SSLITHQLIHTGRKP | 366 | Q3MIS6 | |
| ISLSSLINHKSVHPG | 571 | Q8NB50 | |
| STLTTHNIIHTGEIP | 206 | Q03924 | |
| LTSVHLARHTPTGTL | 71 | Q9C0K7 | |
| RSSLREHLQIHTGVP | 266 | Q8N680 | |
| TDLIRHQTVHTGERP | 476 | Q6P9A1 | |
| SLLRSVSPSQVHHGS | 1066 | Q9ULL1 | |
| SALTEHQRIHTGEKP | 491 | Q6P280 | |
| VAERSQLGAHHTTPV | 6 | Q5BJD5 | |
| THLQQPSTARGHLLV | 121 | Q9BZR9 | |
| VLSSPHGRRQHLAVS | 1901 | Q5T4S7 | |
| TTHLIHQPAGSRSLE | 326 | Q5T5U3 | |
| TTSAPLIRRQLSHDH | 846 | Q5T5U3 | |
| SSLTIHQRVHTGEKP | 171 | Q9NQZ8 | |
| SSLTVHQRIHTGEKP | 451 | Q9NQZ8 | |
| SELTLHQRIHTGEKP | 571 | Q7Z3V5 | |
| LTVHLRSHTGDTPFQ | 401 | Q9NTW7 | |
| SHSTLIQHQPLHTGE | 796 | A8MQ14 | |
| THLTLHQRIHTGDRP | 966 | A8MQ14 | |
| STLDTHQRIHTGERP | 511 | P17021 | |
| LLQHQSSHTGERPFL | 361 | Q14929 | |
| STLARHRSIHTGEKP | 791 | Q6ZNA1 | |
| SELTLHQRIHTGEKP | 286 | Q8TAF7 | |
| AGHQEVATRLLHSPL | 496 | Q96C45 | |
| SSLIQHERTHTGEKP | 566 | Q8TF47 | |
| SSLIVHLRNHTGEKP | 721 | Q8WXB4 | |
| TLKPNLTIHQRTHSG | 526 | Q9Y3M9 | |
| SSLIQHERIHTGEKP | 416 | Q8N7M2 | |
| HTVPDISIHGNLSSV | 2221 | Q5THJ4 | |
| SSLTRHQISHSGEKP | 321 | Q9NR11 | |
| HGSVHNLSLPESTLL | 371 | Q96NY9 | |
| GLVPEHVETRTLHST | 1736 | Q9NZM1 | |
| SHPGLLQDQRITHIL | 226 | Q96NY8 |